GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Gross Profit

Lanzhou Foci Pharmaceutical Co (SZSE:002644) Gross Profit : ¥326.3 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co Gross Profit?

Lanzhou Foci Pharmaceutical Co's gross profit for the three months ended in Sep. 2024 was ¥62.9 Mil. Lanzhou Foci Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ¥326.3 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Lanzhou Foci Pharmaceutical Co's gross profit for the three months ended in Sep. 2024 was ¥62.9 Mil. Lanzhou Foci Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was ¥209.7 Mil. Therefore, Lanzhou Foci Pharmaceutical Co's Gross Margin % for the quarter that ended in Sep. 2024 was 30.00%.

Lanzhou Foci Pharmaceutical Co had a gross margin of 30.00% for the quarter that ended in Sep. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Lanzhou Foci Pharmaceutical Co was 33.00%. The lowest was 22.14%. And the median was 28.29%.


Lanzhou Foci Pharmaceutical Co Gross Profit Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co Gross Profit Chart

Lanzhou Foci Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.19 165.39 223.15 305.21 361.30

Lanzhou Foci Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.64 99.42 85.31 78.71 62.89

Competitive Comparison of Lanzhou Foci Pharmaceutical Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Lanzhou Foci Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lanzhou Foci Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lanzhou Foci Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lanzhou Foci Pharmaceutical Co's Gross Profit falls into.



Lanzhou Foci Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lanzhou Foci Pharmaceutical Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1163.134 - 801.838
=361.3

Lanzhou Foci Pharmaceutical Co's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=209.651 - 146.761
=62.9

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥326.3 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Lanzhou Foci Pharmaceutical Co's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=62.9 / 209.651
=30.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Lanzhou Foci Pharmaceutical Co  (SZSE:002644) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lanzhou Foci Pharmaceutical Co had a gross margin of 30.00% for the quarter that ended in Sep. 2024 => Competition eroding margins


Lanzhou Foci Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Lanzhou Foci Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046
Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australian, Russia, Ukraine, among others.
Executives
Sun Yu Directors, executives
Su Wen Bo Supervisors
An Wen Ting Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines